标题
Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
作者
关键词
-
出版物
Cancers
Volume 12, Issue 12, Pages 3724
出版商
MDPI AG
发表日期
2020-12-14
DOI
10.3390/cancers12123724
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Astrocytes monitor cerebral perfusion and control systemic circulation to maintain brain blood flow
- (2020) Nephtali Marina et al. Nature Communications
- Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
- (2020) E. Antonio Chiocca et al. Molecular Therapy-Methods & Clinical Development
- Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma
- (2020) Timothy F. Cloughesy et al. JAMA Oncology
- The enhanced tumor specificity of TG6002, an armed-oncolytic vaccinia virus deleted in two genes involved in nucleotide metabolism
- (2019) Johann Foloppe et al. Molecular Therapy-Oncolytics
- First-in-human phase I trial of the combination of two adenoviral vectors expressing HSV1-TK and FLT3L for the treatment of newly diagnosed resectable malignant glioma: Initial results from the therapeutic reprogramming of the brain immune system.
- (2019) Pedro R. Lowenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1
- (2019) Samiah A. Al-Zaidy et al. PEDIATRIC NEUROLOGY
- Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas
- (2019) Hong Jiang et al. CLINICAL CANCER RESEARCH
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- DNX-2401: an investigational drug for the treatment of recurrent glioblastoma
- (2019) Brandon Philbrick et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
- (2019) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
- (2018) John A. Barrett et al. CANCER GENE THERAPY
- Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients
- (2018) Daniel J Hogan et al. CLINICAL CANCER RESEARCH
- Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients
- (2018) Pedro R. Lowenstein et al. CLINICAL IMMUNOLOGY
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Herpes Simplex Virus 1 Mutant with Point Mutations in UL39 Is Impaired for Acute Viral Replication in Mice, Establishment of Latency, and Explant-Induced Reactivation
- (2018) Heba H. Mostafa et al. JOURNAL OF VIROLOGY
- Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
- (2018) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells
- (2017) Xiaoyin Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
- (2017) Karsten Geletneky et al. MOLECULAR THERAPY
- Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
- (2017) Ken Y Chan et al. NATURE NEUROSCIENCE
- Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates
- (2017) Kevin A. Cassady et al. Molecular Therapy-Oncolytics
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- 61. Ascending Dose Trials of a Retroviral Replicating Vector (Toca 511) in Patients with Recurrent High-Grade Glioma: Clinical Update, Molecular Analyses, and Proposed Mechanism of Action
- (2016) Douglas J. Jolly et al. MOLECULAR THERAPY
- In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
- (2016) Keiichiro Suzuki et al. NATURE
- Advances in the molecular genetics of gliomas — implications for classification and therapy
- (2016) Guido Reifenberger et al. Nature Reviews Clinical Oncology
- Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
- (2016) Lee A. Wheeler et al. NEURO-ONCOLOGY
- Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
- (2016) Timothy F. Cloughesy et al. Science Translational Medicine
- Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
- (2015) Sajeel A. Chowdhary et al. JOURNAL OF NEURO-ONCOLOGY
- DDEL-06PRELIMINARY SAFETY OF TOCA 511, A RETROVIRAL REPLICATING VECTOR, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ACROSS THREE SEPARATE PHASE 1 STUDIES
- (2015) Steven N. Kalkanis et al. NEURO-ONCOLOGY
- Oncolytic parvoviruses: from basic virology to clinical applications
- (2015) Antonio Marchini et al. Virology Journal
- Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma
- (2015) Nan Ji et al. Oncotarget
- Designing herpes viruses as oncolytics
- (2015) Cole Peters et al. Molecular Therapy-Oncolytics
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
- (2014) James M Markert et al. MOLECULAR THERAPY
- Lactate-mediated glia-neuronal signalling in the mammalian brain
- (2014) F. Tang et al. Nature Communications
- Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model
- (2013) T T Huang et al. CANCER GENE THERAPY
- Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
- (2012) Karsten Geletneky et al. BMC CANCER
- Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
- (2012) Omar D Perez et al. MOLECULAR THERAPY
- On the origin of glioma
- (2012) Yiwen Jiang et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Adenovirus E1A Directly Targets the E2F/DP-1 Complex
- (2011) P. Pelka et al. JOURNAL OF VIROLOGY
- Targeted methylation of CMV and E1A viral promoters
- (2010) Chia-Chen Hsu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Astrocytes Control Breathing Through pH-Dependent Release of ATP
- (2010) A. V. Gourine et al. SCIENCE
- Integrin αvβ5 is a primary receptor for adenovirus in CAR-negative cells
- (2010) Cynthia Lyle et al. Virology Journal
- The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin
- (2009) I. Lazar et al. JOURNAL OF VIROLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
- (2008) M. Schaich et al. ANNALS OF ONCOLOGY
- Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo
- (2008) Beihui Liu et al. BMC BIOTECHNOLOGY
- A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma
- (2008) E Antonio Chiocca et al. MOLECULAR THERAPY
- A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas
- (2008) Peter Forsyth et al. MOLECULAR THERAPY
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
- (2008) James M Markert et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now